This inventor holds 1 USPTO granted patent. Top assignee: Bayer Aktiengesellschaft. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Gabriele Bräunlich: Innovator in Pharmaceutical Chemistry
Introduction
Gabriele Bräunlich is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of innovative compounds for medical applications. His work focuses on addressing critical health issues, such as anemia.
Latest Patents
Gabriele Bräunlich holds a patent for "6-carboxyphenyldihydropyridazinone derivatives and use thereof." This invention relates to specific derivatives that have potential applications in treating anemias. The patent outlines a process for preparing these materials, as well as pharmaceutical compositions containing them.
Career Highlights
Bräunlich is associated with Bayer Aktiengesellschaft, a leading global pharmaceutical and life sciences company. His role at Bayer has allowed him to engage in cutting-edge research and development, contributing to advancements in medical treatments.
Collaborations
Throughout his career, Gabriele Bräunlich has collaborated with esteemed colleagues, including Jürgen Stoltefuss and Michael Lögers. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Gabriele Bräunlich's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions continue to pave the way for new treatments and improved health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile